Elamipretide vs Lixisenatide
Head-to-head comparison of Elamipretide (Elamipretide (MTP-131, SS-31)) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Elamipretide | Lixisenatide |
|---|---|---|
| Category | Muscle & Performance | Weight Management |
| Full Name | Elamipretide (MTP-131, SS-31) | Exendin-4-derived GLP-1 receptor agonist |
| Molecular Weight | 639.8 Da | 4858 Da |
| Half-Life | 1-4 hours | 2-4 hours |
| Amino Acids | 4 | 44 |
| Typical Dose | 0.01-0.25 mg/kg/day | 10-20 mcg daily |
| Route | Subcutaneous/Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 400 |
| Research Status | Clinical | Approved |
Elamipretide Benefits
- ✓mitochondrial protection
- ✓reduced oxidative stress
- ✓improved fatigue resistance
- ✓may support exercise tolerance
Lixisenatide Benefits
- ✓postprandial glucose control
- ✓modest weight loss
- ✓appetite reduction
- ✓short-acting option
Elamipretide Dosing
0.01-0.25 mg/kg/day SC (clinical research)|daily dosing in trials|alternative IV protocols in some studies
Lixisenatide Dosing
10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day
Elamipretide Side Effects
- ⚠nausea
- ⚠injection-site reactions
- ⚠diarrhea
- ⚠headache
Lixisenatide Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠hypoglycemia when combined with insulin
Research Overview
Elamipretide
Clinical and translational studies show elamipretide can improve mitochondrial function and some functional endpoints in mitochondrial disorders. Skeletal muscle research suggests benefits are driven by energy metabolism rather than direct muscle-building effects.
Lixisenatide
Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.